The novel coronavirus, named SARS-CoV-2, is now rapidly spreading across the world after originating in the city of Wuhan, China. Human-to-human transmission of this virus has been identified in familial case cluster reports, and additional cases continue to be confirmed in different cities and countries around the world.
To develop therapeutic strategies, neutralizing antibody (NAb) is emerged and establishes the best evidence that protective immunity has been provided and biological tests of neutralization reveal a correlation with protection. Creative Biolabs has long-term devoted to the development and application of phage display technology. With years of experience, our scientists have developed several phage display based platforms and tailored hundreds of particular libraries. We are pleased to use our extensive experience and advanced platform to offer custom services of phage display library screening for the development of neutralizing antibody to SARS-CoV-2.
Check more details: Phage Display Library Screening for SARS-CoV-2
Add comment
Comments